-
Mashup Score: 0Proactive CAD strategies fueled by calcium scores lead to benefits for intermediate-risk patients - 2 month(s) ago
Up to 50% of all patients face an intermediate risk of developing CAD, and the optimal treatment strategy for that population remains unclear. For this study, researchers explored data from more than 400 intermediate-risk patients with a family history of premature CAD.
Source: cardiovascularbusiness.comCategories: General Medicine NewsTweet
-
Mashup Score: 0Proactive CAD strategies fueled by calcium scores lead to benefits for intermediate-risk patients - 2 month(s) ago
Up to 50% of all patients face an intermediate risk of developing CAD, and the optimal treatment strategy for that population remains unclear. For this study, researchers explored data from more than 400 intermediate-risk patients with a family history of premature CAD.
Source: cardiovascularbusiness.comCategories: General Medicine NewsTweet-
Proactive CAD strategies fueled by calcium scores lead to benefits for intermediate-risk patients https://t.co/t5K1GNsAQl
-
-
Mashup Score: 0Proactive CAD strategies fueled by calcium scores lead to benefits for intermediate-risk patients - 2 month(s) ago
Up to 50% of all patients face an intermediate risk of developing CAD, and the optimal treatment strategy for that population remains unclear. For this study, researchers explored data from more than 400 intermediate-risk patients with a family history of premature CAD.
Source: cardiovascularbusiness.comCategories: General Medicine NewsTweet-
Proactive CAD strategies fueled by calcium scores lead to benefits for intermediate-risk patients https://t.co/t5K1GNsAQl
-
-
Mashup Score: 0Proactive CAD strategies fueled by calcium scores lead to benefits for intermediate-risk patients - 2 month(s) ago
Up to 50% of all patients face an intermediate risk of developing CAD, and the optimal treatment strategy for that population remains unclear. For this study, researchers explored data from more than 400 intermediate-risk patients with a family history of premature CAD.
Source: cardiovascularbusiness.comCategories: General Medicine NewsTweet-
Proactive CAD strategies fueled by calcium scores lead to benefits for intermediate-risk patients https://t.co/t5K1GNsAQl
-
-
Mashup Score: 3Yes, physicians warn, cannabis is bad for the heart - 5 month(s) ago
Cannabis use is on the rise throughout the United States, but it is not as harmless as some people may believe. An in-depth analysis out of Stanford explored the many cardiovascular risks associated with regular cannabis use.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
Yes, physicians warn, cannabis is bad for the heart https://t.co/5IFv6xH40n #journalofduh
-
-
Mashup Score: 3Yes, physicians warn, cannabis is bad for the heart - 5 month(s) ago
Cannabis use is on the rise throughout the United States, but it is not as harmless as some people may believe. An in-depth analysis out of Stanford explored the many cardiovascular risks associated with regular cannabis use.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
Yes, physicians warn, cannabis is bad for the heart https://t.co/5IFv6xH40n #journalofduh
-
-
Mashup Score: 4FDA clears AI screening tool for cardiac amyloidosis - 6 month(s) ago
Ultromics designed EchoGo Amyloidosis to evaluate routine echocardiogram results for signs of cardiac amyloidosis. It received the FDA’s breakthrough device designation back in 2023.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
FDA clears AI screening tool for cardiac amyloidosis https://t.co/sbJkSf2NjQ #AICardiology
-
-
Mashup Score: 3FDA clears AI screening tool for cardiac amyloidosis - 7 month(s) ago
Ultromics designed EchoGo Amyloidosis to evaluate routine echocardiogram results for signs of cardiac amyloidosis. It received the FDA’s breakthrough device designation back in 2023.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
FDA clears AI screening tool for cardiac amyloidosis https://t.co/sbJkSf2NjQ #AICardiology
-
-
Mashup Score: 3FDA clears AI screening tool for cardiac amyloidosis - 7 month(s) ago
Ultromics designed EchoGo Amyloidosis to evaluate routine echocardiogram results for signs of cardiac amyloidosis. It received the FDA’s breakthrough device designation back in 2023.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
FDA clears AI screening tool for cardiac amyloidosis https://t.co/sbJkSf2NjQ #AICardiology
-
-
Mashup Score: 3FDA clears AI screening tool for cardiac amyloidosis - 7 month(s) ago
Ultromics designed EchoGo Amyloidosis to evaluate routine echocardiogram results for signs of cardiac amyloidosis. It received the FDA’s breakthrough device designation back in 2023.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
FDA clears AI screening tool for cardiac amyloidosis https://t.co/sbJkSf2NjQ #AICardiology
-
Proactive CAD strategies fueled by calcium scores lead to benefits for intermediate-risk patients https://t.co/t5K1GNsAQl